Corrigendum to “WCN24-786 PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Pages S368-S369]
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-08-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924017649 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850126685828022272 |
|---|---|
| author | Zhiming Ye Li Fan Rui Yan Bicheng Liu Linghui Zhou Guangqun Xing Wei Zhao Zunsong Wang Deguang Wang Min Zhang Xin Zhang Xinyu Yang Xue Yang Xueqing Yu |
| author_facet | Zhiming Ye Li Fan Rui Yan Bicheng Liu Linghui Zhou Guangqun Xing Wei Zhao Zunsong Wang Deguang Wang Min Zhang Xin Zhang Xinyu Yang Xue Yang Xueqing Yu |
| author_sort | Zhiming Ye |
| collection | DOAJ |
| format | Article |
| id | doaj-art-9e0fb96705be43f2bc32cbeed8131f3c |
| institution | OA Journals |
| issn | 2468-0249 |
| language | English |
| publishDate | 2024-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-9e0fb96705be43f2bc32cbeed8131f3c2025-08-20T02:33:51ZengElsevierKidney International Reports2468-02492024-08-01982579258010.1016/j.ekir.2024.06.005Corrigendum to “WCN24-786 PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Pages S368-S369]Zhiming Ye0Li Fan1Rui Yan2Bicheng Liu3Linghui Zhou4Guangqun Xing5Wei Zhao6Zunsong Wang7Deguang Wang8Min Zhang9Xin Zhang10Xinyu Yang11Xue Yang12Xueqing Yu13Nephrology, Guangdong Provincial People’s Hospital, Guangzhou; Correspondence: Zhiming YeNephrology, Guangdong Provincial People’s Hospital, GuangzhouNephrology, The Affiliated Hospital of Guizhou Medical University, GuizhouNephrology, Institute of Nephrology, Zhong Da Hospital, Southeast University, NanjingNephrology, The First Affiliated Hospital of Xiamen University, XiamenNephrology, The Affiliated Hospital of Qingdao University, QingdaoDrug Clinical Research Center, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, JinanNephrology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, JinanNephrology, The Second Hospital of Anhui Medical University, HefeiNephrology, Liuzhou Workers Hospital, LiuzhouClinical Research Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd., ShanghaiClinical Research Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd., NanjingClinical Research Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd., ShanghaiNephrology, Guangdong Provincial People’s Hospital, Guangzhouhttp://www.sciencedirect.com/science/article/pii/S2468024924017649 |
| spellingShingle | Zhiming Ye Li Fan Rui Yan Bicheng Liu Linghui Zhou Guangqun Xing Wei Zhao Zunsong Wang Deguang Wang Min Zhang Xin Zhang Xinyu Yang Xue Yang Xueqing Yu Corrigendum to “WCN24-786 PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Pages S368-S369] Kidney International Reports |
| title | Corrigendum to “WCN24-786 PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Pages S368-S369] |
| title_full | Corrigendum to “WCN24-786 PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Pages S368-S369] |
| title_fullStr | Corrigendum to “WCN24-786 PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Pages S368-S369] |
| title_full_unstemmed | Corrigendum to “WCN24-786 PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Pages S368-S369] |
| title_short | Corrigendum to “WCN24-786 PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Pages S368-S369] |
| title_sort | corrigendum to wcn24 786 phase i dose escalation study of shr6508 a calcium sensing receptor agonist in hemodialysis patients with secondary hyperparathyroidism kidney international reports volume 9 issue 4 supplement april 2024 pages s368 s369 |
| url | http://www.sciencedirect.com/science/article/pii/S2468024924017649 |
| work_keys_str_mv | AT zhimingye corrigendumtowcn24786phaseidoseescalationstudyofshr6508acalciumsensingreceptoragonistinhemodialysispatientswithsecondaryhyperparathyroidismkidneyinternationalreportsvolume9issue4supplementapril2024pagess368s369 AT lifan corrigendumtowcn24786phaseidoseescalationstudyofshr6508acalciumsensingreceptoragonistinhemodialysispatientswithsecondaryhyperparathyroidismkidneyinternationalreportsvolume9issue4supplementapril2024pagess368s369 AT ruiyan corrigendumtowcn24786phaseidoseescalationstudyofshr6508acalciumsensingreceptoragonistinhemodialysispatientswithsecondaryhyperparathyroidismkidneyinternationalreportsvolume9issue4supplementapril2024pagess368s369 AT bichengliu corrigendumtowcn24786phaseidoseescalationstudyofshr6508acalciumsensingreceptoragonistinhemodialysispatientswithsecondaryhyperparathyroidismkidneyinternationalreportsvolume9issue4supplementapril2024pagess368s369 AT linghuizhou corrigendumtowcn24786phaseidoseescalationstudyofshr6508acalciumsensingreceptoragonistinhemodialysispatientswithsecondaryhyperparathyroidismkidneyinternationalreportsvolume9issue4supplementapril2024pagess368s369 AT guangqunxing corrigendumtowcn24786phaseidoseescalationstudyofshr6508acalciumsensingreceptoragonistinhemodialysispatientswithsecondaryhyperparathyroidismkidneyinternationalreportsvolume9issue4supplementapril2024pagess368s369 AT weizhao corrigendumtowcn24786phaseidoseescalationstudyofshr6508acalciumsensingreceptoragonistinhemodialysispatientswithsecondaryhyperparathyroidismkidneyinternationalreportsvolume9issue4supplementapril2024pagess368s369 AT zunsongwang corrigendumtowcn24786phaseidoseescalationstudyofshr6508acalciumsensingreceptoragonistinhemodialysispatientswithsecondaryhyperparathyroidismkidneyinternationalreportsvolume9issue4supplementapril2024pagess368s369 AT deguangwang corrigendumtowcn24786phaseidoseescalationstudyofshr6508acalciumsensingreceptoragonistinhemodialysispatientswithsecondaryhyperparathyroidismkidneyinternationalreportsvolume9issue4supplementapril2024pagess368s369 AT minzhang corrigendumtowcn24786phaseidoseescalationstudyofshr6508acalciumsensingreceptoragonistinhemodialysispatientswithsecondaryhyperparathyroidismkidneyinternationalreportsvolume9issue4supplementapril2024pagess368s369 AT xinzhang corrigendumtowcn24786phaseidoseescalationstudyofshr6508acalciumsensingreceptoragonistinhemodialysispatientswithsecondaryhyperparathyroidismkidneyinternationalreportsvolume9issue4supplementapril2024pagess368s369 AT xinyuyang corrigendumtowcn24786phaseidoseescalationstudyofshr6508acalciumsensingreceptoragonistinhemodialysispatientswithsecondaryhyperparathyroidismkidneyinternationalreportsvolume9issue4supplementapril2024pagess368s369 AT xueyang corrigendumtowcn24786phaseidoseescalationstudyofshr6508acalciumsensingreceptoragonistinhemodialysispatientswithsecondaryhyperparathyroidismkidneyinternationalreportsvolume9issue4supplementapril2024pagess368s369 AT xueqingyu corrigendumtowcn24786phaseidoseescalationstudyofshr6508acalciumsensingreceptoragonistinhemodialysispatientswithsecondaryhyperparathyroidismkidneyinternationalreportsvolume9issue4supplementapril2024pagess368s369 |